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Original ArticleHepatic expression of lipopolysaccharide-
binding protein (Lbp) is induced by the gut
microbiota through Myd88 and impairs glucose
tolerance in mice independent of obesityAntonio Molinaro 1,5, Ara Koh 1,2,5, Hao Wu 1, Marc Schoeler 1, Maria Ilaria Faggi 1, Alba Carreras 1,
Anna Hallén 1, Fredrik Bäckhed 1,3,4, Robert Caesar 1,*ABSTRACT
Objective: Gut-derived inflammatory factors can impair glucose homeostasis, but the underlying mechanisms are not fully understood. In this
study, we investigated how hepatic gene expression is regulated by gut colonization status through myeloid differentiation primary response 88
(MYD88) and how one of the regulated genes, lipopolysaccharide-binding protein (Lbp), affects insulin signaling and systemic glucose
homeostasis.
Methods: Liver transcriptomics analysis was conducted on four groups of mice fed a chow diet: conventionally raised (CONV-R) wild-type, germ-
free (GF) wild-type, CONV-R Myd88 KO, and GF Myd88 KO. Primary hepatocytes were exposed to combinations of lipopolysaccharide (LPS), LBP,
and the LBP-blocking peptide LBPK95A, and the effect on insulin signaling was determined. To assess how LBP affects glucose metabolism
in vivo, two mouse models were applied: treatment with LBPK95A and hepatic knockdown of Lbp using CRISPR-CAS9.
Results: We showed that the colonization status regulates gene expression in the liver and that a subset of these genes, including Lbp, is
regulated through MYD88. Furthermore, we demonstrated that LBP impairs insulin signaling in hepatocytes in the presence of low levels of LPS
and that the effect of LBP is abolished by LBPK95A. We showed that both systemic pharmacological blocking of LBP by LBPK95A and CRISPR-
CAS9-mediated downregulation of hepatic Lbp improve glucose homeostasis.
Conclusions: Our results demonstrate that the gut microbiota regulates hepatic expression of Lbp through MYD88-dependent signaling. LBP
potentiates LPS inhibition of insulin signaling in vitro and impairs systemic glucose homeostasis in vivo.
 2020 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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The gut microbiota is an important regulator of host metabolism in
health and disease [1] The influence of the gut microbiota on host
metabolism has been extensively studied using germ-free (GF) mice,
which display a better metabolic phenotype than conventionally raised
(CONV-R) mice, both on a chow diet and during metabolic challenges
such as a Western diet [2e4].
The gut microbiota influences host metabolism through several
mechanisms. Bacterially produced metabolites interact with host re-
ceptors involved in metabolic control, both in the gut and peripheral
organs [5e7]. Microbe-associated molecular patterns (MAMPs) are
microbially produced metabolites with conserved molecular motifs
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For personal use only. No other uses without permisfrom the gut into the body can activate inflammatory pathways and
may contribute to the development of pathophysiological conditions
such as impaired glucose metabolism [4,8e10]. Toll-like receptors
(TLRs) are a group of cellular receptors recognizing MAMPs. Most TLRs
require the adaptor molecule myeloid differentiation primary response
88 (MYD88) to activate downstream targets [11]. TLRs and MYD88 are
expressed in immune cells such as macrophages as well as in many
other cell types including hepatocytes [12,13]. Consumption of a
Western-style diet, obesity, and impaired glucose homeostasis are
associated with increased plasma levels of TLR ligands such as lipo-
polysaccharide (LPS) [8,14], but LPS is also present in the plasma of
healthy human subjects [15] and in lean mice fed a chow diet [4,8].
However, it is unclear at present whether LPS impairs glucose
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Abbreviations
GF germ free
CONV-R conventionally raised
MAMP microbe-associated molecular pattern
LPS lipopolysaccharide
KO knockout
TLR Toll-like receptor
MYD88 myeloid differentiation primary response 88
TRIF TIR-domain-containing adapter-inducing interferon-b
LBP lipopolysaccharide-binding protein
IU infectious units
ANOVA analysis of variance
Saa2 serum amyloid A2
Atp11b probable phospholipid-transporting ATPase IF
Adgrf adhesion G protein-coupled receptors
Hsd3b2 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid
delta-isomerase 2
Original ArticleIn this study, we conducted transcriptome profiling on liver tissue from
GF and CONV-R wild-type and Myd88 knockout (KO) mice fed a chow
diet to investigate how interactions between the gut microbiota and the
immune system influence the expression of genes related to glucose
metabolism. We also investigated how hepatic lipopolysaccharide-
binding protein (LBP), which we found to be induced by the gut
microbiota through MYD88, affects insulin signaling and systemic
glucose homeostasis.
2. MATERIALS AND METHODS
2.1. Mouse experiments
Tissue samples for transcriptome profiling were harvested from male
C57Bl6/J mice maintained under CONV-R or GF conditions as
described in a previously published study [16]. Four groups of mice
were included: CONV-R wild-type, GF wild-type, CONV-R Myd88 KO,
and GF Myd88 KO. The mice were maintained on a 12-h cycle (light
from 7 am to 7 pm) and fed an autoclaved chow diet (LabDiet, St.
Louis, MO, USA) and water ad libitum. The mice were kept in cages
with 3e5 mice in each cage. The GF mice were maintained in flexible
film isolators. The mice were killed by cervical dislocation after 4 h of
fasting. The Myd88 KO mice were backcrossed at least eight gener-
ations to C57Bl6/J and the last two crossings were conducted using
mice from our colony and thereafter separated by a maximum of two
generations. The GF and CONV-R mice were separated by a maximum
of three generations.
To deplete the gut microbiota by antibiotics treatment, 100 mg/mL
neomycin, 50 mg/mL streptomycin, 100 U/ml ampicillin, 50 mg/mL
vancomycin, 100 mg/mL metronidazole, 1 mg/mL bacitracin, 125 mg/
mL ciprofloxacin, and 100 mg/mL ceftazidime were administered in the
drinking water ad libitum and replaced with freshly prepared cocktails
three times a week. The mice were treated with antibiotics for five
weeks.
To study how interactions between LPS and LBP affect systemic
glucose homeostasis in vivo, wild-type CONV-R mice were adminis-
trated 3 intraperitoneal injections for 24 h (time point 0, 12 and 24 h)
with the LBP-blocking peptide LBPK95A [17] (5 mg/kg; sequence:
RVQGRWKVRASFFK; GeneScript, Piscataway, NJ) or 0.9% sodium
chloride the day before the glucose tolerance test.
To knock out Lbp in vivo, the mice were injected with 3x109 infectious
units (IU) Ad5-CMV-CAS9 and 3  109 IU Ad5-U6-sgRNA-Lbp retro-2 MOLECULAR METABOLISM 37 (2020) 100997  2020 The Authors. Published by Elsevier G
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as negative controls (Sirion, Planegg, Germany). A glucose tolerance
test was conducted after 5 weeks and the mice were killed after 7
weeks. To assess the efficiency of the knockout, proteins were
extracted from the liver and epididymal adipose tissue and LBP were
quantified by Western blotting.
The animal protocols were approved by the Research Animal Ethics
Committee in Gothenburg.
2.2. CRISPR/CAS9 construct
A series of three candidate oligonucleotide guide cassettes targeting
exon 1 of the Lbp gene were cloned into the plasmid pENTR-U6-
tracRNA and verified by sequencing. To test the efficiency of the
sgRNA sequence, a DNA fragment containing the target sites of the
sgRNAs to be tested was cloned out of frame to the N-terminus of the
eGFP coding region in plasmid pENTR-CMV-MCS-eGFP. Reporter cells
were transfected with the vectors pENTR-U6-sgRNA-LBP (guide),
pENTR-CMV-spCAS9 (CAS9), and pENTR-CMV-LBP-target-sites-eGFP
(reporter). A strand break at the target site in front of the GFP gene
resulting in a frameshift mutations and subsequent expression of GFP
indicated the construct’s efficiency. The guide sequence
CGGTGTCAACCCCGGTGTGG efficiently induced GFP and the U6-
sgRNA-LBP-cassette containing this sequence was recombined into
an Ad5 vector. Cloning success was verified by restriction analysis and
DNA sequencing. Amplification was conducted in HEK293 cells and
viral particles were purified via CsCl2 purification.
2.3. Quantitative PCR
Quantitative PCR (qPCR) to enumerate bacterial 16S rRNA gene copies
in the genomic DNA extracted from cecal samples was conducted as
previously described [18]. The total amount of bacterial DNA was
quantified with the universal primers UniF (50 GTGSTGCAYG-
GYYGTCGTCA-30) and UniR (50-ACGTCRTCCMCNCCTTCCTC-30) using
the 16S rRNA gene of Escherichia coli W3310 as standard.
Determination of the relative gene expression in the primary hepato-
cytes and liver tissue was conducted by qPCR as previously described
[3]. The gene expression data were normalized to the ribosomal
protein L32. The primer sequences used in this study were L32F
(CCTCTGGTGAAGCCCAAGATC), L32R (CTGGGTTTCCGCCAGTTT), LbpF
(GATCACCGACAAGGGCCTG), and LbpR (GGCTATGAAACTCGTACTGCC).
2.4. RNA isolation, microarray processing, and statistical analysis
RNA isolation and microarray processing were conducted as previously
described [16] Briefly, liver RNA was isolated using an RNeasy Mini Kit
(Qiagen, Hilden, Germany). The RNA concentration and quality were
evaluated by spectrophotometric analysis (ND-1000; NanoDrop
Technologies, Wilmington, DE, USA) and capillary electrophoresis on a
2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA).
RNA labeling, microarray hybridization, and scanning were conducted
at the Uppsala array platform core facility at Uppsala University using
MoGene 1.0 ST chips (Affymetrix, Santa Clara, CA, USA) according to
the manufacturer’s instructions. Normalization and probe set sum-
marization were conducted using Affymetrix expression console soft-
ware. Genes were annotated against the ENSEMBL17 set of genes
using the MoGene 1.0 ST probe set mapping provided using BioMart
[19]. Overall, 22,398 unique genes were obtained and then normalized
by the robust multi-array average method (background-adjusted,
normalized, and log-transformed) using the oligo package [20,21] for
further downstream data analyses. A hierarchical modeling approach
combining generalized linear regression and empirical Bayes statistics
within the limma package (version 3.34.9) [22] was used to access thembH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1: Analysis of hepatic gene expression quantified by microarray in the CONV-R and GF wild-type and Myd88 KO mice. (A) Principle component analysis of
transcriptional data. PC1, principal component 1; PC2, principal component 2. (B) Venn diagram showing the numbers of genes significantly regulated by the gut microbiota (at a
5% false discovery rate) in the wild-type mice (beige), Myd88 KO mice (red), and both strains (intersection between circles). Genes more than 2-fold upregulated (C) or
downregulated (D) in the CONV-R wild-type mice compared to the CONVR Myd88 KO mice, GF wild-type mice, and GF Myd88 KO mice. Wild-type CONV-R, n ¼ 5; wild-type GF,
n ¼ 3; Myd88 CONV-R, n ¼ 5; Myd88 GF, n ¼ 6. *P < 0.05, **P < 0.01, and ***P < 0.001 determined by one-way analysis of variance and using Tukey’s multiple
comparisons test. Hierarchical multivariate statistical analysis of the genes presented in C-D resulted in the following P values: Lbp: Pmicro ¼ 0.00015, Pgeno ¼ 0.30,
Pinteraction ¼ 0.0092; Saa2: Pmicro ¼ 0.00020, Pgeno ¼ 0.45, Pinteraction ¼ 0.0075; Atp11a: Pmicro ¼ 6.8e-06, Pgeno ¼ 0.044, Pinteraction ¼ 0.0045; Adgrf1: Pmicro ¼ 7.9e-05,
Pgeno ¼ 0.047, Pinteraction ¼ 0.026; Hsd3b2: Pmicro ¼ 2.4e-06, Pgeno ¼ 0.10, Pinteraction ¼ 0.0063.differential gene expression with the following formula:
microbiota þ genotype þ interaction. Multiple testing correction was
adjusted by the default Benjamini-Hochberg method [23]. The
normalized abundance table for those differentially expressed genes
were used for principal component analysis (PCA). Microarray data for
wild-type mice were partly analyzed in a previous report [24]. CEL filesMOLECULAR METABOLISM 37 (2020) 100997  2020 The Authors. Published by Elsevier GmbH. This is
www.molecularmetabolism.com
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(accession number GSE31115).
2.5. Preparation of primary hepatocytes and in vitro experiments
Primary mouse hepatocytes were isolated by perfusing the liver with
collagenase type IV as previously described [25]. After perfusion,an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 3
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Original Article1.6  106 cells were plated on collagen-coated 60 mm dishes in
Dulbecco’s modified Eagle’s medium (DMEM)/F12 (Thermo Fisher)
supplemented with fetal bovine serum (Thermo Fisher), penicillin/
streptomycin, and 100 nM dexamethasone (Sigma Aldrich). After 4 h,
the medium was changed to DMEM/F12 containing penicillin/strep-
tomycin. After 14 h, primary hepatocytes were cultured in DMEM/F12
with or without LPS (diluted with water), LBP (R&D Systems, 870-LP-
025, diluted with 0.1% BSA in PBS), or LBPK95A (diluted with 0.1%
BSA in PBS) for 8 h and treated with 5 nM insulin for the times indi-
cated in Figure 3. The primary mouse hepatocytes in the experiment
presented in Figure 2C were treated with LPS or supernatant from RAW
264.7 (pretreated with LPS for 24 h) for 24 h. RAW 264.7 macrophages
were cultivated as previously described [4].
2.6. Western blotting
Snap-frozen tissues and harvested cells were lysed in buffer A con-
taining 50 mM TriseHCl (pH 7.4), 150 mM NaCl, 1 mM ethyl-
enediaminetetraacetic acid, 1 mM Na3VO4, 20 mM NaF, 10 mM
glycerophosphate, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10%
glycerol, 1% Triton X-100, and protease inhibitor cocktail. For Western
blotting, the cell lysates were sonicated and centrifuged at 20,000 g for
15 min at 4 C, and the supernatant was mixed with 5X Laemmli
buffer, 0.156 M Trizma hydrochloride (pH 6.8), 25% glycerol, 12.5%
b-mercaptoethanol, 12.5% sodium dodecyl sulfate (SDS), and 0.1%
bromophenol blue followed by heating at 95 C for 10 min. The
samples (20e25 mg) treated with Laemmli buffer were separated on
Bis-Tris gels, transferred to nitrocellulose membrane, and probed with
the indicated antibodies. The blots were then reacted with horseradish
peroxidase (HRP)-linked anti-rabbit IgG or anti-mouse IgG followed by
enhanced chemiluminescence. Antibodies are reported in online
Supplementary Table 1.
2.7. MRI, glucose tolerance, and insulin measurement
MRI, glucose tolerance tests, and measurements of insulin levels were
conducted as previously described [4]. Briefly, glucose tolerance tests
were performed by injecting glucose (2 g/kg body weight) intraperi-
toneally after a 5 h fast. Tail blood samples were collected at 30, 0,Figure 2: Antibiotics treatment decreases hepatic Lbp expression and supernatan
primary hepatocytes. (A) Bacterial count in the cecum. (B) Hepatic Lbp expression. (C) Exp
macrophages treated with LPS. n ¼ 6e8 (AeB); n ¼ 4 (C). *P < 0.05**, P < 0.01, and *
using Tukey’s multiple comparisons test (C).
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using a glucose meter (Accu Check Aviva, Roche). Insulin levels were
measured with a Crystal Chem kit (Downers Grove, IL, USA) according
to the manufacturers’ protocols.
2.8. Immunohistochemistry of epididymal adipose tissue and liver
Paraffin-embedded epididymal adipose tissue and liver sections
(7 mm) were processed as previously described [3]. Slides were
stained with hematoxylin and quantitated by densitometric analysis
using Biopix iQ software (version 2.1.3; Biopix, Sweden).
2.9. Statistical analysis
Statistical analyses were conducted using R and GraphPad Prism 7.
Two-sided Student’s t-tests were used to compare two groups. One-
way ANOVA with Tukey’s multiple comparison were used to compare
three or more groups. For tests of four groups measuring the effect of
two factors, 2-way ANOVA tests with Sidak’s multiple comparisons
were used. For tests between groups with repeated measurements, a
2-way ANOVA test for repeated measurement with Tukey’s multiple
comparison was used.
3. RESULTS AND DISCUSSION
3.1. Gut colonization status regulates the expression of hepatic
genes related to LPS transport and cellular signaling through MYD88
The GF mice fed a chow diet had improved glucose tolerance [2,4] and
reduced inflammation [3] compared to the CONVR mice. To investigate
how colonization status affects the expression of genes associated
with glucose metabolism through MYD88-dependent signaling, tran-
scriptome analysis was conducted by microarray on liver samples from
the GF and CONV-R wild-type and Myd88 KO mice. To specifically
assess the effect of bacterially derived inflammatory factors, we
avoided the use of a high-fat diet since long-chain saturated fatty acids
induce inflammation [26] and therefore may confound the signal.
Principle component analysis of gene expression showed that the mice
separated on colonization status in the first dimension and genotype in
the second dimension (Figure 1A). This was similar to what wet from RAW 264.7 macrophages pretreated with LPS induces Lbp expression in
ression of Lbp in primary hepatocytes treated with LPS or supernatant from RAW 264.7
**P < 0.001 determined by Student’s t-test (AeB) or one-way analysis of variance and
mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 3: Interaction between LPS and LBP increases JNK phosphorylation and decreases IRS1 phosphorylation in response to insulin in primary hepatocytes. (A)
Immunoblot showing the effect of LPS exposure on phosphorylation of IRS1 (Y612) and JNK in response to insulin. (B) Immunoblot showing the effect of LBP exposure on
phosphorylation of IRS1 (Y612) and JNK in response to insulin in the presence of LPS. (C) Semi-quantitative analysis of the phosphorylation levels in panel B. (D) Immunoblot
showing the effect of the LBP-blocking peptide LBPK95A on phosphorylation of IRS1 (Y612) and JNK in response to insulin in the presence of LPS and LBP. (E) Semi-quantitative
analysis of the phosphorylation levels in panel D. n ¼ 3. **P < 0.01 and ***P < 0.001 determined by one-way analysis of variance and using Tukey’s multiple comparisons test
between all of the groups.previously observed for gene expression in the duodenum, ileum, and
colon [16]. The GF mice of both genotypes clustered close together,
suggesting that MYD88 is important for gut microbiota signaling in the
liver. A biplot combining the PCA presented in Figure 1A with theMOLECULAR METABOLISM 37 (2020) 100997  2020 The Authors. Published by Elsevier GmbH. This is
www.molecularmetabolism.com
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associated with CONV-R wild-type mice (Supplementary Figure 1).
Among a total of 22,398 genes, 791 (3.5%) were regulated by colo-
nization status (Figure 1B). To focus on microbially regulated functionsan open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 5
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Original Articledependent on MYD88, microbially regulated genes in the Myd88 KO
mice (Myd88 KO and CONV-R/GF) were subtracted from microbially
regulated genes in the wild-type mice (wild-type and CONV-R/GF),
resulting in 111 genes (Figure 1B, beige circle, left section). These
genes were enriched in the gene ontology (GO) categories LPS
transport, sterol biosynthetic process, and regulation of ERK1 and
ERK2 cascade (Supplementary Table 2). GO categories related to sterol
metabolism were also regulated by colonization status in the Myd88
KO mice (red circle, Figure 1B). Hence, only cellular processes related
to LPS transport and cellular signaling were exclusively affected by
colonization status in the wild-type mice. Next, to identify genes
specifically and strongly regulated in the CONV-R wild-type mice, the
dataset was filtered for genes that were more than 2-fold up- or
downregulated in this group compared to all of the other groups. Saa2,
Lbp, and Atp11b were found to be induced (Figure 1C) while Adgrf1
and Hsd3b2 were found to be suppressed (Figure 1D) in the CONV-R
wild-type mice. Hierarchical multivariate analysis of the genes in
Figure 1CeD (Saa2, Lbp, Atp11b, Atp11a, and Adgrf1) showed that
colonization status had a significant (P < 0.05) impact on the
expression of all genes while the genotype affected the expression of
Atp11a and Adgrf1. The interaction between gut microbiota and ge-
notype was significant for all of the genes.
Taken together, we showed that a group of hepatic genes mainly
related to LPS transport and cellular signaling are regulated by gut
colonization status through MYD88.
3.2. LBP is induced by the gut microbiota and inhibits insulin
signaling in hepatocytes
Among genes identified as regulated by colonization status through
Myd88, we chose to focus on Lbp since increased serum levels of LBP
are strongly associated with impaired glucose homeostasis and type 2
diabetes in humans [27e32]. LBP is an acute phase protein that fa-
cilitates immune signaling by presenting LPS to TLR4 [33], and the
administration of LPS induces hyperglycemia, hyperinsulinemia, and
insulin resistance in mice and humans [34,35].
To further investigate how the gut microbiota affects the expression of
hepatic Lbp, we treated the mice with a broad-spectrum cocktail of
antibiotics for 5 weeks. Antibiotics treatment depleted 99.9% of the
bacteria in the cecum (Figure 2A). The expression of Lbp significantly
decreased in the mice receiving antibiotics compared to the control
mice (Figure 2B). This is in line with the observed decrease in Lbp
expression in the GF mice (Figure 1C) and supports our hypothesis that
Lbp may be regulated by the gut microbiota.
Next, to investigate putative mechanisms by which MAMPSs can
induce Lbp expression, we treated primary hepatocytes with 1 ng/mL
(physiological range level [4,34]) or 10 ng/mL LPS for 24 h. LPS
treatment did not affect Lbp expression (Figure 2C). Acute phase
proteins such as LBP produced by hepatocytes are known to be
regulated by cytokines secreted from activated immune cells [36].
Hence, we treated the primary hepatocytes with supernatant from
untreated RAW 264.7 macrophages or RAW 264.7 macrophages
pretreated with 1 ng/mL or 10 ng/mL LPS. While supernatant from the
untreated macrophages did not induce Lbp expression, supernatant
from the macrophages pretreated with LPS significantly increased Lbp
expression (Figure 2C). These results suggest that low levels of LPS
can indirectly stimulate Lbp expression in hepatocytes through in-
teractions with immune cells in vitro.
LPS exposure induces JNK phosphorylation [37] and insulin resistance
[38] in hepatocytes. However, the LPS levels applied in in vitro and
in vivo studies are usually higher than naturally occurring levels
[15,35,38]. We thus investigated if LBP can potentiate the effect of LPS6 MOLECULAR METABOLISM 37 (2020) 100997  2020 The Authors. Published by Elsevier G
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LPS. First, we found that 10 ng/mL but not 1 ng/mL of LPS impaired
insulin signaling by decreasing IRS-1 tyrosine phosphorylation (Y612)
and increasing c-Jun N-terminal kinase (JNK) phosphorylation
(Figure 3A). When cells were co-incubated with 1 ng/mL of LPS along
with LBP, insulin-stimulated IRS1 phosphorylation decreased and JNK
phosphorylation increased (Figure 3B,C). Next, to investigate if LBP
potentiates the effect of LPS on insulin signaling via interaction be-
tween LPS and LBP, we co-incubated LPS and LBP with LBP-blocking
peptide LBPK95A [17]. LBPK95A efficiently abolished the effect of LBP
and restored insulin signaling (Figure 3D,E).
Taken together, these results show that LBP impairs insulin signaling
in hepatocytes in the presence of low concentrations of LPS in vitro.
3.3. Systemic pharmacologic blocking or genetic downregulation
of hepatic LBP improves glucose homeostasis
To investigate how interaction between LPS and LBP affects glucose
metabolism in vivo, we treated weight-matched CONV-R mice with
LBPK95A or vehicle for 24 h. Fasting glucose levels decreased in the
mice treated with LBPK95A compared to vehicle (Figure 4A), while the
fasting insulin levels did not differ significantly between the groups
(p ¼ 0.2; Figure 4B). The mice treated with LBPK95A exhibited
improved glucose tolerance compared to the mice receiving vehicle
(Figure 4CeD). These data suggest that LBP can impair glucose ho-
meostasis in vivo, possibly through interactions with LPS.
Lbp is mainly expressed in the liver and adipose tissue [39]. While the
present study demonstrated that the gut microbiota induces Lbp
expression in the liver (Figure 1C), we previously showed that it does
not affect expression in adipose tissue [24]. To investigate the link
between microbial regulation of LBP and glucose homeostasis, we
knocked down Lbp in the liver but not adipose tissue. The CONV-R
mice were transduced with an adenovirus vector carrying a CRISPR/
Cas9-construct targeting Lbp or a negative control vector. After 5
weeks, we conducted an intraperitoneal glucose tolerance test, and
after 7 weeks, we sacrificed the mice. Consistent with previous reports
showing that systemic delivery of recombinant adenovirus predomi-
nantly transduces genes into the liver [40] and not adipose tissue [41],
Western blotting analysis revealed that the mice treated with CRISPR/
Cas9-Lbp reduced hepatic LPB levels by approximately 50% compared
to the mice receiving negative control vector, while the LBP levels in
the epididymal adipose tissue were not affected by adenovirus treat-
ment (Supplementary Figure 2). Body weight gain, fat mass/lean mass
ratio, and adipocyte size did not differ between the treatment group
and control group (Figure 5AeD). Neither did the levels of hepatic
steatosis, inflammation, or fibrosis (Supplementary Figure 3). How-
ever, the mice treated with CRISPR/Cas9-Lbp had decreased fasting
glucose and insulin levels (Figure 5EeF) and improved glucose
tolerance compared to the control mice (Figure 5GeH).
Taken together, these results indicated that systemic blocking of LBP
or decreased LBP levels in the liver improve glucose homeostasis,
mainly by decreasing fasting glucose levels, but do not affect adiposity
or steatosis.
Gavaldà-Navarro et al. reported that Lbp KO mice are leaner than wild-
type mice but surprisingly also have impaired glucose metabolism
[42]. The discrepancy to the in vivo models presented in our study may
have several explanations. First, we used a blocking peptide to inhibit
binding of LPS for 24 h. Features of the Lbp KO, such as increased
adipose tissue browning [42], may take longer to develop. LBP may
also have other functions apart from LPS binding that are not affected
by the blocking peptide. For example, LBP has been shown to catalyze
the exchange of phospholipids [43]. A direct link between interactionsmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 4: Blocking of interaction between LPS and LBP with LBPK95A in vivo improves systemic glucose metabolism. (A) Fasting glucose levels, (B) fasting insulin levels,
and (CeD) glucose tolerance in the mice treated with LBPK95A or saline control. n ¼ 5. *P < 0.05 and **P < 0.01 determined by Student’s t-test.
Figure 5: CRISPR CAS9-mediated knockdown of Lbp improves systemic glucose metabolism. (A) Body weight gain, (B) ratio between fat mass and lean mass, (C)
representative hematoxylin staining of epididymal adipose tissue (scale bars ¼ 100 mm), (D) frequency of adipocyte sizes, (E) fasting glucose levels, (F) fasting insulin levels, and
(GeH) glucose tolerance in the mice treated with CRISPR CAS9-Lbp or adenovirus negative control. n ¼ 14. *P < 0.05, **P < 0.01, and ***P < 0.001 determined by Student’s
t-test.
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Original Articlebetween LPS and LBP and glucose homeostasis was not previously
demonstrated. Second, while Gavaldà-Navarro et al. studied the effect
of whole-body knockout, our CRISPR-CAS9 model decreased LBP
levels in the liver but not in adipose tissue. LBP has been shown to
have a major impact on adipose tissue cell differentiation and energy
balance [27,42,44]. Hence, the results from these models are not
comparable. The metabolic features of an adipose tissue-specific Lbp
KO remain to be investigated.
4. CONCLUSIONS
In summary, we showed that the gut microbiota increases the
expression of Lbp in the liver through MYD88. We also demonstrated
that the LBP-blocking peptide LBP95A improves insulin signaling in
hepatocytes as well as systemic glucose metabolism. Furthermore, we
showed that knockdown of LBP in the liver results in improved sys-
temic glucose homeostasis. The present study demonstrated that in-
flammatory factors from the gut microbiota may affect glucose
homeostasis independent of adiposity, and we suggest that LBP pro-
duced by hepatocytes may constitute a link between gut microbiota
and glucose metabolism.
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